• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

构建用于研究心肌肥厚的体外器官型模型。

Engineering an in vitro organotypic model for studying cardiac hypertrophy.

机构信息

Centre for Biosystems Science and Engineering, Indian Institute of Science, Bangalore, 560012, India.

Department of Materials Engineering, Indian Institute of Science, Bangalore, 560012, India.

出版信息

Colloids Surf B Biointerfaces. 2018 May 1;165:355-362. doi: 10.1016/j.colsurfb.2018.02.036. Epub 2018 Feb 27.

DOI:10.1016/j.colsurfb.2018.02.036
PMID:29518684
Abstract

Neonatal cardiomyocytes cultured on flat surfaces are commonly used as a model to study cardiac failure of diverse origin. A major drawback of such a system is that the cardiomyocytes do not exhibit alignment, organization and calcium transients, similar to the native heart. Therefore, there is a need to develop in vitro platforms that recapitulate the cellular microenvironment of the murine heart as organotypic models to study cardiovascular diseases. In this study, we report an engineered platform that mimics cardiac cell organization and function of the heart. For this purpose, microscale ridges were fabricated on silicon using ultraviolet lithography and reactive ion etching techniques. Physical characterization of the microstructures was done using scanning electron microscopy and atomic force microscopy. Cardiomyocytes grown on these micro-ridges showed global parallel alignment and elliptical nuclear morphology as observed in the heart. Interestingly, calcium currents traversed the engineered cardiomyocytes in a coordinated and directional manner. Moreover, the cardiomyocytes on the engineered substrates were found to be responsive to hypertrophic stimuli, as observed by the expression of a fetal gene, atrial natriuretic peptide and increase in calcium transients upon agonist treatment. Taken together, our work demonstrates that micro-ridges can be used to obtain cardiomyocyte response in vitro, which closely resembles mammalian heart.

摘要

在平面表面上培养的新生儿心肌细胞通常被用作研究不同来源心力衰竭的模型。这种系统的一个主要缺点是心肌细胞不会表现出类似于天然心脏的排列、组织和钙瞬变。因此,需要开发能够再现鼠心脏器官型模型的细胞微环境的体外平台来研究心血管疾病。在这项研究中,我们报告了一种模仿心脏细胞组织和心脏功能的工程平台。为此,使用紫外光刻和反应离子刻蚀技术在硅上制造了微尺度脊。使用扫描电子显微镜和原子力显微镜对微结构进行了物理特性表征。在这些微脊上生长的心肌细胞表现出全局平行排列和心脏中观察到的椭圆形核形态。有趣的是,钙电流以协调和定向的方式穿过工程化的心肌细胞。此外,在工程化基质上的心肌细胞对肥大刺激有反应,如通过表达胎儿基因、心钠肽和激动剂处理时钙瞬变的增加来观察到的。总之,我们的工作表明,微脊可用于体外获得类似于哺乳动物心脏的心肌细胞反应。

相似文献

1
Engineering an in vitro organotypic model for studying cardiac hypertrophy.构建用于研究心肌肥厚的体外器官型模型。
Colloids Surf B Biointerfaces. 2018 May 1;165:355-362. doi: 10.1016/j.colsurfb.2018.02.036. Epub 2018 Feb 27.
2
A simplified protocol for culture of murine neonatal cardiomyocytes on nanoscale keratin coated surfaces.一种在纳米级角蛋白涂层表面培养小鼠新生心肌细胞的简化方案。
Int J Cardiol. 2017 Apr 1;232:160-170. doi: 10.1016/j.ijcard.2017.01.036. Epub 2017 Jan 9.
3
Terminal differentiation, advanced organotypic maturation, and modeling of hypertrophic growth in engineered heart tissue.工程化心脏组织中的终末分化、高级器官型成熟和肥厚生长建模。
Circ Res. 2011 Oct 28;109(10):1105-14. doi: 10.1161/CIRCRESAHA.111.251843. Epub 2011 Sep 15.
4
Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca²⁺-mediated calcineurin/NFATc3 and CaMKII signaling cascades.黄芪多糖通过抑制Ca²⁺介导的钙调神经磷酸酶/NFATc3和CaMKII信号级联反应来抑制异丙肾上腺素诱导的心肌肥大。
Environ Toxicol Pharmacol. 2014 Jul;38(1):263-71. doi: 10.1016/j.etap.2014.05.008. Epub 2014 Jun 13.
5
Carbonic anhydrase inhibition prevents and reverts cardiomyocyte hypertrophy.碳酸酐酶抑制可预防并逆转心肌细胞肥大。
J Physiol. 2007 Feb 15;579(Pt 1):127-45. doi: 10.1113/jphysiol.2006.123638. Epub 2006 Nov 23.
6
JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.JunD通过负向调节AP-1转录活性减轻去氧肾上腺素介导的心肌细胞肥大。
Cardiovasc Res. 2006 Jul 1;71(1):108-17. doi: 10.1016/j.cardiores.2006.02.032. Epub 2006 Mar 7.
7
COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.COX-2 参与 ET-1 诱导的新生大鼠心肌细胞肥大:NFATc3 的作用。
Mol Cell Endocrinol. 2014 Feb 15;382(2):998-1006. doi: 10.1016/j.mce.2013.11.012. Epub 2013 Nov 26.
8
The functional properties of nephronectin: an adhesion molecule for cardiac tissue engineering.纤连蛋白的功能特性:心脏组织工程的黏附分子。
Biomaterials. 2012 Jun;33(17):4327-35. doi: 10.1016/j.biomaterials.2012.03.021. Epub 2012 Mar 20.
9
Metformin suppresses phenylephrine-induced hypertrophic responses by inhibiting p300-HAT activity in cardiomyocytes.二甲双胍通过抑制心肌细胞中的p300组蛋白乙酰转移酶活性来抑制去氧肾上腺素诱导的肥大反应。
J Pharmacol Sci. 2021 Oct;147(2):169-175. doi: 10.1016/j.jphs.2021.07.001. Epub 2021 Jul 6.
10
Atrial natriuretic peptide inhibits cardiomyocyte hypertrophy through mitogen-activated protein kinase phosphatase-1.心房利钠肽通过丝裂原活化蛋白激酶磷酸酶-1抑制心肌细胞肥大。
Biochem Biophys Res Commun. 2004 Sep 10;322(1):310-9. doi: 10.1016/j.bbrc.2004.07.119.

引用本文的文献

1
Architecture design and advanced manufacturing of heart-on-a-chip: scaffolds, stimulation and sensors.芯片上心脏的架构设计与先进制造:支架、刺激与传感器
Microsyst Nanoeng. 2024 Jul 11;10:96. doi: 10.1038/s41378-024-00692-7. eCollection 2024.
2
Cellular Senescence Program is Sensitive to Physical Differences in Polymeric Tissue Scaffolds.细胞衰老程序对聚合组织支架中的物理差异敏感。
ACS Mater Au. 2023 Oct 6;4(1):35-44. doi: 10.1021/acsmaterialsau.3c00057. eCollection 2024 Jan 10.
3
Integrated Manufacturing of Suspended and Aligned Nanofibrous Scaffold for Structural Maturation and Synchronous Contraction of HiPSC-Derived Cardiomyocytes.
用于人诱导多能干细胞衍生心肌细胞结构成熟和同步收缩的悬浮排列纳米纤维支架的一体化制造
Bioengineering (Basel). 2023 Jun 9;10(6):702. doi: 10.3390/bioengineering10060702.
4
A designer cell culture insert with a nanofibrous membrane toward engineering an epithelial tissue model validated by cellular nanomechanics.一种带有纳米纤维膜的设计型细胞培养插入物,用于构建经细胞纳米力学验证的上皮组织模型。
Nanoscale Adv. 2021 Jul 5;3(16):4714-4725. doi: 10.1039/d1na00280e. eCollection 2021 Aug 10.
5
Breakthroughs and Applications of Organ-on-a-Chip Technology.器官芯片技术的突破与应用。
Cells. 2022 Jun 2;11(11):1828. doi: 10.3390/cells11111828.
6
Designing Biomaterial Platforms for Cardiac Tissue and Disease Modeling.用于心脏组织和疾病建模的生物材料平台设计
Adv Nanobiomed Res. 2021 Jan;1(1). doi: 10.1002/anbr.202000022. Epub 2020 Oct 16.
7
Poly(Ethylene Glycol) Functionalized Graphene Oxide in Tissue Engineering: A Review on Recent Advances.聚乙二醇功能化氧化石墨烯在组织工程中的应用:最新进展综述。
Int J Nanomedicine. 2020 Aug 12;15:5991-6006. doi: 10.2147/IJN.S249717. eCollection 2020.
8
New Insights and Current Approaches in Cardiac Hypertrophy Cell Culture, Tissue Engineering Models, and Novel Pathways Involving Non-Coding RNA.心肌肥厚细胞培养、组织工程模型及涉及非编码RNA的新途径的新见解与当前方法
Front Pharmacol. 2020 Aug 21;11:1314. doi: 10.3389/fphar.2020.01314. eCollection 2020.
9
Hollow Alginate-Poly-L-Lysine-Alginate Microspheres Promoted an Epithelial-Mesenchymal Transition in Human Colon Adenocarcinoma Cells.中空藻酸盐-聚-L-赖氨酸-藻酸盐微球促进人结肠腺癌细胞上皮-间质转化
Adv Pharm Bull. 2020 Jan;10(1):141-145. doi: 10.15171/apb.2020.019. Epub 2019 Dec 11.